AR013468A1 - GONADOTROPINS EXPRESSED IN DICTYOSTELIUM - Google Patents
GONADOTROPINS EXPRESSED IN DICTYOSTELIUMInfo
- Publication number
- AR013468A1 AR013468A1 ARP980104442A ARP980104442A AR013468A1 AR 013468 A1 AR013468 A1 AR 013468A1 AR P980104442 A ARP980104442 A AR P980104442A AR P980104442 A ARP980104442 A AR P980104442A AR 013468 A1 AR013468 A1 AR 013468A1
- Authority
- AR
- Argentina
- Prior art keywords
- dictyostelium
- gonadotropins
- expressed
- gonadotropin
- mutants
- Prior art date
Links
- 102000006771 Gonadotropins Human genes 0.000 title abstract 4
- 108010086677 Gonadotropins Proteins 0.000 title abstract 4
- 239000002622 gonadotropin Substances 0.000 title abstract 4
- VUDQSRFCCHQIIU-UHFFFAOYSA-N 1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one Chemical compound CCCCCC(=O)C1=C(O)C(Cl)=C(OC)C(Cl)=C1O VUDQSRFCCHQIIU-UHFFFAOYSA-N 0.000 title abstract 3
- 241000224495 Dictyostelium Species 0.000 title abstract 3
- 229940094892 gonadotropins Drugs 0.000 title abstract 3
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Toxicology (AREA)
- Reproductive Health (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Gonadotropinas expresadas en Dictyostelium que se ha encontrado que se secretan en una forma biologicamente activa. La expresion de las gonadotropinasen Dictyostelium proporciona un camino fácil para seleccionar mutantes de gonadotropinas.Gonadotropins expressed in Dictyostelium that have been found to be secreted in a biologically active form. Expression of gonadotropins in Dictyostelium provides an easy way to select gonadotropin mutants.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97202757 | 1997-09-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR013468A1 true AR013468A1 (en) | 2000-12-27 |
Family
ID=8228713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980104442A AR013468A1 (en) | 1997-09-08 | 1998-09-07 | GONADOTROPINS EXPRESSED IN DICTYOSTELIUM |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1012290A1 (en) |
JP (1) | JP2001515721A (en) |
KR (1) | KR20010023749A (en) |
CN (1) | CN1269834A (en) |
AR (1) | AR013468A1 (en) |
AU (1) | AU746780B2 (en) |
BR (1) | BR9812043A (en) |
CA (1) | CA2302647A1 (en) |
HU (1) | HUP0004599A3 (en) |
IL (1) | IL134589A0 (en) |
NO (1) | NO20001178L (en) |
NZ (1) | NZ502964A (en) |
PL (1) | PL339259A1 (en) |
TR (1) | TR200000618T2 (en) |
WO (1) | WO1999013081A1 (en) |
ZA (1) | ZA987497B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001058493A1 (en) * | 2000-02-11 | 2001-08-16 | Maxygen Aps | Conjugates of follicle stimulating hormones |
AU2001267337A1 (en) * | 2000-06-30 | 2002-01-14 | Maxygen Aps | Peptide extended glycosylated polypeptides |
EA009330B1 (en) * | 2001-09-12 | 2007-12-28 | Апплайд Резеч Системз Арс Холдинг Н.В. | Method encouraging implantation rates and/or decreased miscarriage rates and kit therefor |
YU21104A (en) | 2001-09-12 | 2006-08-17 | Applied Research Systems Ars Holding N.V. | Use of hcg and lh in controlled ovarian hyperstimulation |
AU2002324183B2 (en) * | 2001-09-12 | 2007-10-25 | Merck Serono Sa | Use of hCG and LH in controlled ovarian hyperstimulation |
WO2014159813A1 (en) | 2013-03-13 | 2014-10-02 | Moderna Therapeutics, Inc. | Long-lived polynucleotide molecules |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69534723T2 (en) * | 1994-02-18 | 2006-08-31 | Washington University | Single-chain gonadotropin |
US5691455A (en) * | 1995-10-24 | 1997-11-25 | Akzo Nobel N.V. | Gonadotropins with non-native disulfide bridges |
-
1998
- 1998-08-19 ZA ZA987497A patent/ZA987497B/en unknown
- 1998-09-02 AU AU95381/98A patent/AU746780B2/en not_active Ceased
- 1998-09-02 CN CN98808921A patent/CN1269834A/en active Pending
- 1998-09-02 KR KR1020007002404A patent/KR20010023749A/en not_active Application Discontinuation
- 1998-09-02 HU HU0004599A patent/HUP0004599A3/en unknown
- 1998-09-02 IL IL13458998A patent/IL134589A0/en unknown
- 1998-09-02 BR BR9812043-3A patent/BR9812043A/en not_active IP Right Cessation
- 1998-09-02 NZ NZ502964A patent/NZ502964A/en unknown
- 1998-09-02 JP JP2000510866A patent/JP2001515721A/en not_active Withdrawn
- 1998-09-02 TR TR2000/00618T patent/TR200000618T2/en unknown
- 1998-09-02 PL PL98339259A patent/PL339259A1/en not_active Application Discontinuation
- 1998-09-02 WO PCT/EP1998/005717 patent/WO1999013081A1/en not_active Application Discontinuation
- 1998-09-02 CA CA002302647A patent/CA2302647A1/en not_active Abandoned
- 1998-09-02 EP EP98948936A patent/EP1012290A1/en not_active Withdrawn
- 1998-09-07 AR ARP980104442A patent/AR013468A1/en unknown
-
2000
- 2000-03-07 NO NO20001178A patent/NO20001178L/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1012290A1 (en) | 2000-06-28 |
BR9812043A (en) | 2000-10-03 |
HUP0004599A2 (en) | 2001-04-28 |
HUP0004599A3 (en) | 2002-09-30 |
NZ502964A (en) | 2001-08-31 |
ZA987497B (en) | 1999-02-23 |
TR200000618T2 (en) | 2000-09-21 |
PL339259A1 (en) | 2000-12-04 |
IL134589A0 (en) | 2001-04-30 |
KR20010023749A (en) | 2001-03-26 |
NO20001178D0 (en) | 2000-03-07 |
CN1269834A (en) | 2000-10-11 |
AU746780B2 (en) | 2002-05-02 |
CA2302647A1 (en) | 1999-03-18 |
WO1999013081A1 (en) | 1999-03-18 |
NO20001178L (en) | 2000-05-05 |
AU9538198A (en) | 1999-03-29 |
JP2001515721A (en) | 2001-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO4750807A1 (en) | INTERFERON SOLUTION | |
ATE217884T1 (en) | PENTAPEPTIDE METHYLESTERS THAT INHIBIT HUMAN CANCER | |
ES2168414T3 (en) | FORMULATIONS OF RETINOIDS IN POROUS MICROSPHERES OF REDUCED IRRITATION AND INCREASED STABILITY. | |
EE9800387A (en) | Improvement of implantation after in vitro fertilization | |
CO4830493A1 (en) | ANTIBODIES AGAINST HUMAN CD40 | |
DE69433168D1 (en) | IN VITRO PROPAGATION OF STEM CELLS | |
ATE376413T1 (en) | ENCAPSULATION OF BIOLOGICALLY ACTIVE COMPLEXES IN LIPOSOMES | |
CO5180587A1 (en) | ORLISTAT PHARMACEUTICAL COMPOSITION CONTAINING TENSOACTIVE AND DISPERSANT | |
ES2170259T3 (en) | EMPLOYMENT OF LIPIDS AS AUXILIARY AGENTS IN OBTAINING SOLID PHARMACEUTICAL FORMS ACCORDING TO THE FUSION EXTRUSION PROCEDURE. | |
ES2158540T3 (en) | D-MANITOL AND ITS PREPARATION. | |
AR013468A1 (en) | GONADOTROPINS EXPRESSED IN DICTYOSTELIUM | |
AR001200A1 (en) | Procedure for manufacturing a hollow body and said hollow body | |
IT8921096A0 (en) | ELECTRIC ACCUMULATOR WITH HIGH POWER DENSITY FOR PEAK LOADS. | |
IL154662A0 (en) | A multisegment integrated laser and a method for fabrication thereof | |
DE69707082D1 (en) | AMPLIFIERS WITH ACTIVE BOOTSTRAP REINFORCEMENT ENHANCEMENT TECHNOLOGY | |
ES2175135T3 (en) | USE OF GALACTANASE IN ANIMAL FEEDS. | |
IT1297302B1 (en) | PROCEDURE FOR THE MANUFACTURING OF FOOTWEAR AND FOOTWEAR OBTAINED WITH THE SAID PROCEDURE | |
BR0012006A (en) | Method to prevent inflammation, autoimmune diseases and tumor growth, and use of substances that suppress ltbr-mediated activation | |
IT1255123B (en) | LINEAR BEARING WITH ROLLING ROLLING ORGANS WITH CURVED PROFILES | |
MX9306614A (en) | COMPOSITION OF METHODS FOR THE FORMATION OF AN INSECTICIDE. | |
ES2179908T3 (en) | SACAROSAMONOCARBOXILIC ACILATED ACIDS. | |
MX9300026A (en) | PROCEDURE FOR THE PREPARATION OF BENZOESTERS AND BENZOACIDES. | |
IT1282425B1 (en) | IMPROVED PROCEDURE AND SYSTEM FOR THE PRODUCTION OF HOLLOW BODIES IN P.E.T. | |
ES2071342T3 (en) | PHOSPHOLIPID ANALOG VESICULA WITH A RADICAL SUCCINIMIDIL. | |
UY24201A1 (en) | INTERFERÓN SOLUTION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |